1Mayer J,Rau B,Gansauge F,et al.Inflammatory mediators in human acute pancreatitis:clinical and pathophysiological implications.Gut,2000,47(41):546-552.
2Saluja AK,Steer MLP6.Pathophysiology of pancreatitis.Role of cytokines and other mediators of inflammation.Digestion,1999,60(Suppl 1):27-33.
3Gogos CA,Drosou E,Bassaris HP,et al.Pro-versus anti-Inflammatory cytokine profile in patiens with severe sepsis:a marker for prognosis and future therapeutic options.J Infect Dis,2000,181(1):176-180.
5Van Dissel JT,Van Langevelde P,Westendorp RG,et al.Anti-inflammatory cytokines profile and mortality in febrile patients.Lancet,1998,351(9107):950-953.
6Guillaume M,Marie-Emmanuelle F,Fabienne V,et al.The inflammatory response dominates after septic shock:association of low monocyte HLA-DR expression and high interleukin-10 concentration.Immunology Lett,2004,95(2):193-198.
7Lekkou A,Karakantza,M,Mouzaki A,et al.Cytokine Production and Monocyte HLA-DR expression as Predictors of Outcome for Patiens with Community-Acquired Severe Infections.Clin Diagn.Lab Immunol,2004,11(1):161-167.
3[1]Hirassawa H, Sugai T, Oda S, et al. Continous hemodiafiltration can remove humoral mediators from the blood stream of patients with SIRS/MODS. Abstr. Blood Purif,1997, 15:136
4[2]Heering P, Morgera S, Schmitz G, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med, 1997, 23:288
5[3]Kouche K,Cavadore P,Portales P, et al. Continous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNF-α and IL-6 plasma concentrations. J Neprol, 2002, 15:150
6[4]Sander A,Armbruster W,Sander B, et al. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but not alter IL-6 and TNF-α plasma concentrations. Intensive Care Med, 1997, 23:878
7[6]Sieberth HG,Kierdorf HP. Is cytokine removal by continuous hemofiltration feasible? Kidney Int. 1999, 56(Suppl. 72): S79
8[7]Silvester W. Mediator removal with CRRT: complement and cytokines. Am J Kidney Dis, 1997, 30 (Suppl.4): S38
9[8]Sibbald WJ, Vincent JL. Round table conference on clinical trial for the treatment of sepsis. Crit Care Med, 1995, 23:394
10[10]De vriese AS,Colardyn FA,Philipp JJ, et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol, 1999, 10: 846
